tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Travel

tanzania times : Latest News and In-depth Analysis
HomeTravel
Travel

Jan 11, 2025

Trina Storage Retains Top Rank in BloombergNEF's 2024 Global Storage Providers and Integrators Bankability Survey

CHANGZHOU,China,Jan. 10,2025-- Recently,Trina Storage has once again secured a top spot in BloombergNEF\'s (BNEF) Energy Storage System Cost Survey 2024,acknowledged for its cutting-edge products,tec

All News

Travel

HONOR Unveils New Corporate Strategy to Transition to an AI Device Ecosystem Company

Illuminating a three-step roadmap underpinned by openness and collaboration BARCELONA,Spain,March 3,2025-- Global technology brand HONOR today announced the HONOR ALPHA PLAN,a new corporate strategy

Mar 5, 2025

Travel

THE GLEN GRANT'S SPLENDOURS COLLECTION LAUNCHES WITH EXQUISITE 65-YEAR-OLD SINGLE MALT SCOTCH WHISKY

Distilled in Scotland in 1958,the 65-Year-Old is the first from a new collection which features some of the rarest whiskies maturing at The Glen Grant distillery

Mar 5, 2025

Travel

THE ORGANIZATION BEHIND THE WORLD'S 50 BEST RESTAURANTS SETS ITS SIGHTS ON NORTH AMERICA WITH THE DEBUT OF NORTH AMERICA'S 50 BEST RESTAURANTS

First-ever dedicated restaurants ranking for the region announced LONDON,March 3,2025-- North America\'s 50 Best Restaurants,a new awards program highlighting top dining destinations across the Unite

Mar 5, 2025

Travel

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

MELBOURNE,Australia and INDIANAPOLIS,Ind.,March 4,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) invites investors to join a webinar showcasing the Company\'s late-stag

Mar 5, 2025

Travel

Mass production of high-quality, self-standing, large-diameter single-crystal (111) diamond substrates within reach

Development of n-Type Diamonds for Practical Use in Diamond Semiconductors also Making Advances TOKYO,March 4,2025-- Orbray has developed production technology for the world\'s largest self-standing

Mar 5, 2025

Travel

Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]

Mar 5, 2025

1 ... 9 10 11 12 13 14 15 ... 75